{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:01:31Z","timestamp":1793127691776,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijrobp.2024.05.026","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T09:46:39Z","timestamp":1717580799000},"page":"999-1007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Variation in Androgen Deprivation Therapy Use Among Men With Intermediate-Risk Prostate Cancer: Results From a Statewide Radiation Oncology Quality Consortium"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-7669","authenticated-orcid":false,"given":"Michael P.","family":"Dykstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel N.","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying (Maggie)","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick William","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Boike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Mislmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Paluch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale W.","family":"Litzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Mietzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrinda","family":"Narayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Heimburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-3758","authenticated-orcid":false,"given":"Robert T.","family":"Dess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.05.026_bib0001","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2014.58.0662","article-title":"Duration of androgen suppression before radiotherapy for localized prostate cancer: Radiation Therapy Oncology Group randomized clinical trial 9910","volume":"33","author":"Pisansky","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0003","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijrobp.2021.08.031","article-title":"Adding short-term androgen deprivation therapy to radiation therapy in men with localized prostate cancer: long-term update of the NRG\/RTOG 9408 randomized clinical trial","volume":"112","author":"Jones","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0004","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1470-2045(21)00705-1","article-title":"Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis","volume":"23","author":"Kishan","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.292.7.821","article-title":"6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial","volume":"292","author":"D'Amico","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0039","article-title":"Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trial","volume":"4","author":"Michalski","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0007","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized Phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0008","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0009","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ijrobp.2020.06.011","article-title":"Absolute versus relative benefit of androgen deprivation therapy for prostate cancer: moving beyond the hazard ratio to personalize therapy","volume":"108","author":"Spratt","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.eururo.2013.03.033","article-title":"A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy","volume":"64","author":"Zumsteg","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0011","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.22.02390","article-title":"Dose-escalated radiotherapy alone or in combination with short-term androgen deprivation for intermediate-risk prostate cancer: results of a Phase III multi-institutional trial","volume":"41","author":"Krauss","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0012","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1016\/j.prro.2023.04.009","article-title":"Decision regret and bother with the addition of androgen deprivation therapy to definitive radiation treatment for localized prostate cancer","volume":"13","author":"Booth","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0013","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.euo.2018.12.004","article-title":"Patient-reported outcomes following treatment of localised prostate cancer and their association with regret about treatment choices","volume":"3","author":"van Stam","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.euo.2019.01.006","article-title":"Underutilization of androgen deprivation therapy with external beam radiotherapy in men with high-grade prostate cancer","volume":"4","author":"Wang","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0016","article-title":"Trends in androgen deprivation use in men with intermediate-risk prostate cancer who underwent radiation therapy","volume":"7","author":"Agrawal","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0017","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0018","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/jamaoncol.2020.4922","article-title":"Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the international staging collaboration for cancer of the prostate","volume":"6","author":"Dess","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0019","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300023","article-title":"Artificial intelligence predictive model for hormone therapy use in prostate cancer","volume":"2","author":"Spratt","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.6004\/jnccn.2016.0048","article-title":"Variation in national use of long-term ADT by disease aggressiveness among men with unfavorable-risk prostate cancer","volume":"14","author":"Muralidhar","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41391-018-0084-3","article-title":"Practice patterns of primary EBRT with and without ADT in prostate cancer treatment","volume":"22","author":"Schmidt","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0022","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.22.00970","article-title":"Sequencing of androgen-deprivation therapy of short duration with radiotherapy for nonmetastatic prostate cancer (SANDSTORM): a pooled analysis of 12 randomized trials","volume":"41","author":"Ma","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0023","article-title":"Management of prostate cancer radiotherapy during the COVID-19 pandemic: a necessary paradigm change","volume":"27","author":"Detti","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0024","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ijc.34759","article-title":"Impact of the COVID-19 pandemic on delivery of prostate cancer care in Australia: an interrupted time series analysis","volume":"154","author":"Ng Hung Shin","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bju.15740","article-title":"Development and validation of a life expectancy calculator for US patients with prostate cancer","volume":"130","author":"Chase","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0026","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/JU.0000000000000006","article-title":"Facility level variation in rates of definitive therapy for low risk prostate cancer in men with limited life expectancy: an opportunity for value based care redesign","volume":"201","author":"Friedlander","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0027","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/cncr.32719","article-title":"Physician and facility drivers of spending variation in locoregional prostate cancer","volume":"126","author":"Rodin","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0028","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/UPJ.0000000000000290","article-title":"Facility-level variation in use of locoregional therapy for metastatic prostate cancer","volume":"9","author":"Buck","year":"2022","journal-title":"Urol Pract"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0029","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1245\/s10434-019-08110-3","article-title":"Facility-level variation in pelvic lymphadenectomy during radical prostatectomy and effect on overall survival in men with high-risk prostate cancer","volume":"27","author":"Friedlander","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0030","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ijrobp.2020.04.035","article-title":"The role of facility variation on racial disparities in use of hypofractionated whole breast radiation therapy","volume":"107","author":"Laucis","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0031","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clgc.2021.11.012","article-title":"Propensity-weighted survival analysis of SBRT vs. conventional radiotherapy in unfavorable intermediate-risk prostate cancer","volume":"20","author":"Andruska","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41746-022-00613-w","article-title":"Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials","volume":"5","author":"Esteva","year":"2022","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.ijrobp.2024.05.026_bib0033","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.eururo.2020.11.021","article-title":"A systematic review of the evidence for the decipher genomic classifier in prostate cancer","volume":"79","author":"Jairath","year":"2021","journal-title":"Eur Urol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624006898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624006898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T12:30:24Z","timestamp":1729081824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624006898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0360301624006898"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.05.026","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in Androgen Deprivation Therapy Use Among Men With Intermediate-Risk Prostate Cancer: Results From a Statewide Radiation Oncology Quality Consortium","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}